Health Catalyst (HCAT) Common Equity (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Common Equity data on file, last reported at $138.1 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 63.34% year-over-year to $138.1 million; the trailing twelve-month figure through Mar 2026 stood at $138.1 million (down 63.34% YoY), and the FY2025 full-year result was $245.8 million, down 32.7% from the prior year.
• Common Equity for Q1 2026 stood at $138.1 million, down from $245.8 million in the prior quarter.
• Across five years, Common Equity topped out at $480.9 million in Q1 2022 and bottomed at $138.1 million in Q1 2026.
• The 5-year median for Common Equity is $366.9 million (2023), against an average of $366.7 million.
• The widest annual swing landed in 2022, when Common Equity jumped 78.89%; it then slumped 63.34% in 2026.
• A 5-year view of Common Equity shows it stood at $425.0 million in 2022, then dropped by 13.67% to $366.9 million in 2023, then slipped by 0.47% to $365.2 million in 2024, then tumbled by 32.7% to $245.8 million in 2025, then sank by 43.79% to $138.1 million in 2026.
• The last three Common Equity figures came in at $138.1 million (Q1 2026), $245.8 million (Q4 2025), and $331.9 million (Q3 2025), per Business Quant data.

Peer Comparison